Cargando…

miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease

According to the World Health Organization, the continuing surge in obesity pandemic creates a substantial increase in incidences of metabolic disorders, such as non-alcoholic fatty liver disease (NAFLD), type 2 diabetes mellitus, and cardiovascular disease. MicroRNAs (miRNAs) belong to an evolution...

Descripción completa

Detalles Bibliográficos
Autores principales:	López-Pastor, Andrea R., Infante-Menéndez, Jorge, Escribano, Óscar, Gómez-Hernández, Almudena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546803/ https://www.ncbi.nlm.nih.gov/pubmed/33102495 http://dx.doi.org/10.3389/fmed.2020.527059

Ejemplares similares

The Interplay between Oxidative Stress and miRNAs in Obesity-Associated Hepatic and Vascular Complications
por: Infante-Menéndez, Jorge, et al.
Publicado: (2020)

Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease
por: Infante-Menéndez, Jorge, et al.
Publicado: (2023)

Concerted regulation of non-alcoholic fatty liver disease progression by microRNAs in apolipoprotein E-deficient mice
por: López-Pastor, Andrea R., et al.
Publicado: (2021)

miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives
por: Sessa, Francesco, et al.
Publicado: (2023)

Implication of miR-155-5p and miR-143-3p in the Vascular Insulin Resistance and Instability of Human and Experimental Atherosclerotic Plaque
por: González-López, Paula, et al.
Publicado: (2022)

Role and Dysregulation of miRNA in Patients with Parkinson’s Disease
por: Salemi, Michele, et al.
Publicado: (2022)

Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease
por: Mehta, Rohini, et al.
Publicado: (2016)

Liver injury in non-alcoholic fatty liver disease is associated with urea cycle enzyme dysregulation
por: Gallego-Durán, Rocío, et al.
Publicado: (2022)

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
por: Gentile, Giulia, et al.
Publicado: (2022)

Severe Hepatic Insulin Resistance Induces Vascular Dysfunction: Improvement by Liver-Specific Insulin Receptor Isoform A Gene Therapy in a Murine Diabetic Model
por: Gómez-Hernández, Almudena, et al.
Publicado: (2021)

Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts
por: Yang, Fengming, et al.
Publicado: (2017)

Dysregulated miRNAs and their pathogenic implications for the neurometabolic disease propionic acidemia
por: Rivera-Barahona, Ana, et al.
Publicado: (2017)

Protein Binding Partners of Dysregulated miRNAs in Parkinson’s Disease Serum
por: Ruf, Wolfgang P., et al.
Publicado: (2021)

Role of miRNA dysregulation in sepsis
por: Formosa, Amanda, et al.
Publicado: (2022)

Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers
por: Anelli, Luisa, et al.
Publicado: (2021)

Role of miRNAs on the Pathophysiology of Cardiovascular Diseases
por: da Silva, Debora Cristina Pereira, et al.
Publicado: (2018)

Mitochondrial MiRNA in Cardiovascular Function and Disease
por: Song, Rui, et al.
Publicado: (2019)

Correction: Dysregulation of miRNAs expression levels and disease activity in SLE patients
Publicado: (2018)

MiRNA Dysregulation in Childhood Hematological Cancer
por: Carvalho de Oliveira, Jaqueline, et al.
Publicado: (2018)

miRNA Profiling Reveals Dysregulation of RET and RET-Regulating Pathways in Hirschsprung's Disease
por: Li, Shuangshuang, et al.
Publicado: (2016)

miRNA therapeutics in cardiovascular diseases: promises and problems
por: Nouraee, Nazila, et al.
Publicado: (2015)

Editorial: Emerging roles of miRNAs in cardiovascular disease
por: Santovito, Donato, et al.
Publicado: (2023)

Temporal dynamics of miRNAs in human DLPFC and its association with miRNA dysregulation in schizophrenia
por: Hu, Zhonghua, et al.
Publicado: (2019)

Cardiovascular disease in patients with non-alcoholic fatty liver disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Roles of miRNA dysregulation in the pathogenesis of multiple myeloma
por: Chen, Dan, et al.
Publicado: (2021)

Dysregulated RNA polyadenylation contributes to metabolic impairment in non-alcoholic fatty liver disease
por: Jobbins, Andrew M, et al.
Publicado: (2022)

Comprehensive bioinformatics analysis of critical lncRNAs, mRNAs and miRNAs in non-alcoholic fatty liver disease
por: Wu, Huiling, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

Dysregulated plasma levels of miRNA-132 and miRNA-134 in patients with obsessive-compulsive disorder
por: Yue, Jihui, et al.
Publicado: (2020)

Correction: Temporal dynamics of miRNAs in human DLPFC and its association with miRNA dysregulation in schizophrenia
por: Hu, Zhonghua, et al.
Publicado: (2019)

The Interplay Between Gut Microbiota and miRNAs in Cardiovascular Diseases
por: Ionescu, Ruxandra Florentina, et al.
Publicado: (2022)

Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease
por: Ragab, Halla M., et al.
Publicado: (2023)

Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease
por: Spanos, Christos, et al.
Publicado: (2018)

Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease
por: Newman, Lauren A., et al.
Publicado: (2022)

miRNA dysregulation in cancer: towards a mechanistic understanding
por: Palanichamy, Jayanth Kumar, et al.
Publicado: (2014)

Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals
por: Bosutti, Alessandra, et al.
Publicado: (2016)

Exploring dysregulated miRNAs in cryptorchidism: a systematic review
por: Jia, Hongshuai, et al.
Publicado: (2021)

Mechanisms Contributing to the Dysregulation of miRNA-124 in Pulmonary Hypertension
por: Zhang, Hui, et al.
Publicado: (2021)

Characterization of Adrenal miRNA-Based Dysregulations in Cushing’s Syndrome
por: Vetrivel, Sharmilee, et al.
Publicado: (2022)

The dysregulation of miRNAs in epilepsy and their regulatory role in inflammation and apoptosis
por: Xie, Guoping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3o29m46obgphsfgqh7r0nngl34